e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
mTORC1 hyperactivation in lymphangioleiomyomatosis leads to
ACE2
upregulation in type II pneumocytes: implications for COVID-19
Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske
Source:
Eur Respir J, 57 (2) 2002737; 10.1183/13993003.02737-2020
Journal Issue:
February
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske. mTORC1 hyperactivation in lymphangioleiomyomatosis leads to
ACE2
upregulation in type II pneumocytes: implications for COVID-19. Eur Respir J, 57 (2) 2002737; 10.1183/13993003.02737-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lymphangioleiomyomatosis (LAM)
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
The large airway lesions of lymphangioleiomyomatosis: Pathological and radiological analysis
Related content which might interest you:
Angiotensin II and hypoxia synergistically induce proliferation in pulmonary artery fibroblasts by a PI-3K and PKC-signaling pathway through HIF-1 a and upregulation of angiotensin II-receptors type I
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Year: 2002
Overexpression of angiotensin II type 1 receptor (AGTR1) and lymphatic vasculature rarefaction is present in scleroderma with pulmonary compromised
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes
Source: ERJ Open Res, 7 (2) 00713-2020; 10.1183/23120541.00713-2020
Year: 2021
Signal transduction pathways of the interaction of SP-A with its receptor on rat type II pneumocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 476s
Year: 2001
Autocrine secretion of bradykinin prevents alveolar type II cells from mechanical stretch-induced apoptosis by activation – role of PI3K and Akt
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
Influence of protein kinase C on stretch-induced apoptosis in rat alveolar type II cells
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Evidence of type II pneumocyte apoptosis in the murine model of Hermansky-Pudlak-syndrome associated interstitial pneumonia
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Angiotensin II activates the hypoxia-responsive-element (HRE) in human alveolar epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001
Cross-talk between TGFbeta and angiotensin II signalling in lung fibroblast-induced collagen matrix contraction
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Inhibition of bradykinin breakdown by ACE inhibitors reduces mechanical stretch-induced apoptosis of alveolar type II cells
Source: Eur Respir J 2005; 26: Suppl. 49, 345s
Year: 2005
Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Decreased expression of the TGF-beta type I receptor ALK1 in pulmonary arterial hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Effect of hypoxia on gene regulation and differentiation in alveolar epithelial type II cells
Source: Eur Respir J 2001; 18: Suppl. 33, 162s
Year: 2001
Wnt11 inhibits epithelial-mesenchymal transition induced by TGFb1 in human type II alveolar epithelial cells
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Role of TGF-b1 in type I collagen production in bronchial epithelial cells: effects on Smad7 inhibitory role?
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
mTOR signalling is an essential pathway for TGF-β1 induced collagen synthesis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
The role of cell lines in modelling the type II pneumocyte in interstitial lung disease
Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease
Year: 2020
Proliferation of alveolar type II pneumocytes is stimulated by Jagged-1 in vitro
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes
Source: Eur Respir Mon; 2009: 46: 47–66
Year: 2009
High concentrations of VEGF reduce stretch-induced apoptosis of alveolar type II cells
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept